|
DE4338553A1
|
|
Injection syringe for mixing and applying injection substances
|
|
EP0541192A1
|
|
Use of opiate antagonists for the treatment of endogen hyperinsulinemia
|
|
DE4223169C1
|
|
Process for the microencapsulation of water-soluble active substances
|
|
DE3737703A1
|
|
NEUTROPHILE ACTIVATING POLYPEPTIDE, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AS A MEDICINAL PRODUCT AND DIAGNOSTIC
|
|
EP0567205A1
|
|
Use of opiate antagonists in the manufacture of agents for the diagnosis and therapy of hypothalamic function disorders
|
|
DE3631088A1
|
|
USE OF OPIATE ANTAGONISTS FOR DIAGNOSIS AND THERAPY OF HYPOTHALAMIC FUNCTIONAL DISORDERS
|
|
EP0098893A1
|
|
Device for administering liquid medicaments
|
|
DE3205991A1
|
|
POLYPEPTIDES, METHOD FOR THE PRODUCTION THEREOF, THE USE THEREOF AND METHOD FOR CLEANING POLYPEPTIDES
|
|
EP0089950A1
|
|
Polypeptide, preparation method thereof, utilization thereof and pharmaceutical products containing it
|
|
DE3015777A1
|
|
DEVICE FOR INTERMITTENT PULSATORIC APPLICATION OF LIQUID MEDICINAL PRODUCTS
|
|
DE2904484A1
|
|
Promoting factor VIII formation in blood plasma - by administering 1-de:amino-8-D-arginine-vasopressin di:acetate to donors or patients
|
|
CH608788A5
|
|
Process for the preparation of novel peptides having a high adrenocorticotropic action
|
|
DE2449985A1
|
|
Highly adrenocorticotropic peptides prepn - uses tert-butyloxy and tert-butyl ester protective gps during the condensn
|
|
DE2426913A1
|
|
Malonic or succinic acid di(imido ester) prodn. - by reacting dicarboxylic acid dinitriles with anhydrous lower alcohols
|
